The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta‐analysis of randomized controlled trials
Brain and Behavior2019Vol. 9(10), pp. e01409–e01409
Citations Over TimeTop 10% of 2019 papers
Jiangshan Wei, Xiangyu Zhu, Guang Yang, Jun Shen, Peng Xie, Xiaohua Zuo, Lei Xia, Qiu Han, Ying Zhao
Abstract
Pooled data from our meta-analysis suggest that BTX-A is efficacious and safe in treating TN and PNP. However, due to the limited sample size and heterogeneity, further larger and well-designed RCTs are imperative to validate these findings.
Related Papers
- Treatment of acute herpetic neuralgia. A case report and review of the literature.(1990)
- → Effectiveness and safety of lidocaine patch 5% to treat herpes zoster acute neuralgia and to prevent postherpetic neuralgia(2020)17 cited
- → Clinical characteristics and prognostic value of preherpetic neuralgia(2002)3 cited
- Clinical observation on Lipo PGE_1 in combination with cobamamide for neuralgia in patients with herpes zoster(2008)
- Efficacy of floated pin combined with gabapentin therapy for 36 cases with herpes zoster neuralgia(2012)